Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates

Gilead Sciences to Acquire Pharmasset

Skadden is representing Gilead Sciences, Inc. in its $11 billion acquisition of Pharmasset, Inc., announced on November 21.

BACK TO TOP